Co-Authors
This is a "connection" page, showing publications co-authored by Pankaj Bhardwaj and Jaykaran Charan.
Connection Strength
1.559
-
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
Score: 0.238
-
Analysis of Facility and Home Isolation Strategies in COVID 19 Pandemic: Evidences from Jodhpur, India. Infect Drug Resist. 2021; 14:2233-2239.
Score: 0.238
-
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Rev Clin Pharmacol. 2021 Jan; 14(1):95-103.
Score: 0.230
-
Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Indian J Clin Biochem. 2020 Oct 31; 1-4.
Score: 0.228
-
Snapshot of COVID-19 Related Clinical Trials in India. Indian J Clin Biochem. 2020 Oct; 35(4):418-422.
Score: 0.224
-
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int J Gen Med. 2021; 14:3909-3927.
Score: 0.060
-
Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. 2021 Oct; 36(4):427-439.
Score: 0.059
-
Association of Vitamin D Status with COVID-19 Infection and Mortality in the Asia Pacific region: A Cross-Sectional Study. Indian J Clin Biochem. 2021 Oct; 36(4):492-497.
Score: 0.058
-
Household Transmission of COVID-19: A Cross-Sectional Study. Infect Drug Resist. 2020; 13:4637-4642.
Score: 0.058
-
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020; 13:4427-4438.
Score: 0.057
-
Association of Environmental Parameters with COVID-19 in Delhi, India. Indian J Clin Biochem. 2020 Oct; 35(4):497-501.
Score: 0.056
-
Clinical outcome, viral response and safety profile of chloroquine in COVID-19 patients - initial experience. Adv Respir Med. 2020; 88(6):515-519.
Score: 0.054